Literature DB >> 3127529

Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodies.

N C Chien1, R R Pollock, C Desaymard, M D Scharff.   

Abstract

The genetic mechanism responsible for the somatic diversification of two mAbs was determined. The two PC-binding hybridomas were representative of events early and late in the immune response. The P28 cell line that produces an IgM antibody and thus represents events early in the immune response, was found to have 3 bp changes in its heavy chain variable (VH) region, with some changes in antibody affinity or specificity. The RP93 cell line that produces an IgG2a antibody and thus represents later events in the immune response, was found to have 9 bp changes in its VH region resulting in decreased affinity for PC and altered specificity. Oligonucleotides specific for linked base changes in the second hypervariable regions of both of these antibodies were used to look for previously undescribed V regions or other donor sequences that could have been responsible for these base changes. Since no donor sequences were found, we have concluded that somatic point mutation rather than gene conversion, V region replacement or the expression of an unidentified germline VH region gene is truly responsible for at least some of the somatic diversification of these antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127529      PMCID: PMC2188873          DOI: 10.1084/jem.167.3.954

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  57 in total

1.  A hyperconversion mechanism generates the chicken light chain preimmune repertoire.

Authors:  C A Reynaud; V Anquez; H Grimal; J C Weill
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

2.  Highly preferential VH-VL pairing in normal B cells results in antigen-independent selection of the available repertoire.

Authors:  D Primi; A M Drapier; P A Cazenave
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

3.  A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production.

Authors:  M Reth; P Gehrmann; E Petrac; P Wiese
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

4.  Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma.

Authors:  R Kleinfield; R R Hardy; D Tarlinton; J Dangl; L A Herzenberg; M Weigert
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

Review 5.  Mutation drift and repertoire shift in the maturation of the immune response.

Authors:  C Berek; C Milstein
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

Review 6.  Somatic mutation in anti-phosphorylcholine antibodies.

Authors:  U V Malipiero; N S Levy; P J Gearhart
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

Review 7.  Evolution of antibody variable region structure during the immune response.

Authors:  T Manser; L J Wysocki; M N Margolies; M L Gefter
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

8.  Affinity labeling of a phosphorylcholine binding mouse myeloma protein.

Authors:  B Chesebro; H Metzger
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

9.  Variability in the lambda light chain sequences of mouse antibody.

Authors:  M G Weigert; I M Cesari; S J Yonkovich; M Cohn
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

10.  Paucity of phosphorylcholine-specific clones in B cells expressing the VHT15 gene product.

Authors:  D Primi; E Barbier; A M Drapier; P A Cazenave
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Somatic immunoglobulin hypermutation.

Authors:  Marilyn Diaz; Paolo Casali
Journal:  Curr Opin Immunol       Date:  2002-04       Impact factor: 7.486

2.  Altered reactivity of immunoglobulin produced by human-human hybridoma cells transfected by pSV2-neo gene.

Authors:  H Tachibana; K Akiyama; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

3.  Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene.

Authors:  S G Lebecque; P J Gearhart
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

4.  Isolation of germinal centerlike events from human spleen RNA. Somatic hypermutation of a clonally related VH6DJH rearrangement expressed with IgM, IgG, and IgA.

Authors:  W S Varade; R A Insel
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Protein evolution on rugged landscapes.

Authors:  C A Macken; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes.

Authors:  C Huang; A K Stewart; R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

7.  Germ line variable regions that match hypermutated sequences in genes encoding murine anti-hapten antibodies.

Authors:  V David; N L Folk; N Maizels
Journal:  Genetics       Date:  1992-11       Impact factor: 4.562

8.  Somatic mutation in constant regions of mouse lambda 1 light chains.

Authors:  N Motoyama; H Okada; T Azuma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

9.  Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism.

Authors:  N C Chien; V A Roberts; A M Giusti; M D Scharff; E D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Mutation pattern of immunoglobulin transgenes is compatible with a model of somatic hypermutation in which targeting of the mutator is linked to the direction of DNA replication.

Authors:  B Rogerson; J Hackett; A Peters; D Haasch; U Storb
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.